glp-1 breast cancer recurrence glp 1 side effects Could medications play a role in reducing cancer For years, researchers have known
Description
Prolonged lipopolysaccharide-induced illness elevates glucagon-like peptide-1 and suppresses peptide YY: a human-randomized cross-over trial
71 Furthermore, GLP-1RA has been investigated for its potential to reduce the risk of cardiovascular events in patients with or without diabetes
The success of GLP-1 receptor agoniststherapies that exert both central and peripheral effectshas forced a re-evaluation of this cautionary stance
Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG
These medications work by triggering areas in the brain associated with satiety, effectively reducing our desire to overeat
Endocrine 88(1):8090 [DOI] [PubMed] [Google Scholar] 86.Abi Zeid Daou C, Aboul Hosn O, Ghzayel L, Mourad M (2025) Exploring Connections Between Weight-Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database
